SI-BONE(SIBN) - 2024 Q2 - Quarterly Results

Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 Increases 2024 revenue guidance to $165 million -$167 million Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif. August 5, 2024 - SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights (comparisons are to the prior year period) • Worldwide ...